146 related articles for article (PubMed ID: 35237072)
41. Calnexin and calreticulin binding to human thyroperoxidase is required for its first folding step(s) but is not sufficient to promote efficient cell surface expression.
Fayadat L; Siffroi-Fernandez S; Lanet J; Franc JL
Endocrinology; 2000 Mar; 141(3):959-66. PubMed ID: 10698171
[TBL] [Abstract][Full Text] [Related]
42. Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).
Najaoui A; Bakchoul T; Stoy J; Bein G; Rummel MJ; Santoso S; Sachs UJ
Eur J Haematol; 2012 Feb; 88(2):167-74. PubMed ID: 21985182
[TBL] [Abstract][Full Text] [Related]
43. [Mechanism of cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura].
Wang L; Zhang F; Zhu YY; Li LZ; Ma DX; Hou M
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3048-51. PubMed ID: 16324405
[TBL] [Abstract][Full Text] [Related]
44. Investigation on glucocorticoid receptors within platelets from adult patients with immune thrombocytopenia.
Yung KC; Xu CW; Zhang ZW; Yu WJ; Li Q; Xu XR; Han YF; Wang XJ; Yin J
Hematology; 2020 Dec; 25(1):37-42. PubMed ID: 31905108
[No Abstract] [Full Text] [Related]
45. Deficient in vitro megakaryocytopoiesis and decreased in vivo platelet turnover in children and young adults with chronic thrombocytopenia.
Parker RI; Siegel RS; Ratajczak MZ; Gewirtz AM
J Pediatr Hematol Oncol; 1998; 20(3):196-201. PubMed ID: 9628429
[TBL] [Abstract][Full Text] [Related]
46. [Relative analysis of platelet activation with bleeding risk in patients with primary immune thrombocytopenia].
Lyu ME; Li Y; Lyu CC; Liu WJ; Guan Y; Wang SX; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2017 Jan; 38(1):33-38. PubMed ID: 28219222
[No Abstract] [Full Text] [Related]
47. Platelets in idiopathic thrombocytopenic purpura are increased in size but are of normal density.
Illes I; Pfueller SL; Hussein S; Chesterman CN; Martin JF
Br J Haematol; 1987 Oct; 67(2):173-6. PubMed ID: 3676104
[TBL] [Abstract][Full Text] [Related]
48. Hepatitis C virus infection among patients with chronic immune thrombocytopenic purpura in northern India.
Varma S; Kumar S; Garg A; Malhotra P; Das A; Sharma A; Chawla YK; Dhiman RK
J Clin Exp Hepatol; 2011 Sep; 1(2):68-72. PubMed ID: 25755317
[TBL] [Abstract][Full Text] [Related]
49. Kinetics of interactions of sendai virus envelope glycoproteins, F and HN, with endoplasmic reticulum-resident molecular chaperones, BiP, calnexin, and calreticulin.
Tomita Y; Yamashita T; Sato H; Taira H
J Biochem; 1999 Dec; 126(6):1090-100. PubMed ID: 10578061
[TBL] [Abstract][Full Text] [Related]
50. Therapeutic approaches to secondary immune thrombocytopenic purpura.
Bussel JB
Semin Hematol; 2009 Jan; 46(1 Suppl 2):S44-58. PubMed ID: 19245934
[TBL] [Abstract][Full Text] [Related]
51. Vertebral Artery Thrombosis in Chronic Idiopathic Thrombocytopenic Purpura.
Hindi Z; Onteddu N; Ching CA; Khaled AA
Case Rep Hematol; 2017; 2017():3184346. PubMed ID: 28695024
[TBL] [Abstract][Full Text] [Related]
52. Antiplatelet antibodies in chronic immune thrombocytopenia and their role in platelet destruction and defective platelet production.
McMillan R
Hematol Oncol Clin North Am; 2009 Dec; 23(6):1163-75. PubMed ID: 19932426
[TBL] [Abstract][Full Text] [Related]
53. Flow cytometric immunobead assay for quantitative detection of platelet autoantibodies in immune thrombocytopenia patients.
Zhai J; Ding M; Yang T; Zuo B; Weng Z; Zhao Y; He J; Wu Q; Ruan C; He Y
J Transl Med; 2017 Oct; 15(1):214. PubMed ID: 29061180
[TBL] [Abstract][Full Text] [Related]
54. Platelet function in adult ITP patients can be either increased or decreased, compared to healthy controls, and is associated with bleeding risk.
Middelburg RA; Carbaat-Ham JC; Hesam H; Ragusi MA; Zwaginga JJ
Hematology; 2016 Oct; 21(9):549-51. PubMed ID: 27159138
[TBL] [Abstract][Full Text] [Related]
55. Flow cytometry detection of platelets autoantibodies in children with idiopathic thrombocytopenic purpura.
Aref S; Selim T; Ibrahim L; Abd-Elghaffar H; Ashery RE
Indian J Hematol Blood Transfus; 2009 Sep; 25(3):96-103. PubMed ID: 23100985
[TBL] [Abstract][Full Text] [Related]
56. Emerging Concepts in Immune Thrombocytopenia.
Swinkels M; Rijkers M; Voorberg J; Vidarsson G; Leebeek FWG; Jansen AJG
Front Immunol; 2018; 9():880. PubMed ID: 29760702
[TBL] [Abstract][Full Text] [Related]
57. The Association Between Human Leukocyte Antigens and ITP, TTP, and HIT.
Amin Asnafi A; Jalali MT; Pezeshki SMS; Jaseb K; Saki N
J Pediatr Hematol Oncol; 2019 Mar; 41(2):81-86. PubMed ID: 30543580
[TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo assays to assess the functions of calnexin and calreticulin in ER protein folding and quality control.
Paquet ME; Leach MR; Williams DB
Methods; 2005 Apr; 35(4):338-47. PubMed ID: 15804605
[TBL] [Abstract][Full Text] [Related]
59. Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia.
Zhou H; Hou Y; Liu X; Qiu J; Feng Q; Wang Y; Zhang X; Min Y; Shao L; Liu X; Li G; Li L; Yang L; Xu S; Ni H; Peng J; Hou M
Thromb Haemost; 2015 May; 113(5):1021-34. PubMed ID: 25566808
[TBL] [Abstract][Full Text] [Related]
60. The role and mechanism of chaperones Calnexin/Calreticulin in which ALLN selectively rescues the trafficking defective of HERG-A561V mutation.
Wang Y; Shen T; Fang P; Zhou J; Lou K; Cen Z; Qian H; Zhou J; Liu N; Lian J
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 29752336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
